Skip to main content
Clinical Trials/JPRN-UMIN000038192
JPRN-UMIN000038192Completed未知

Efficacy and Safety of Nintedanib in Japanese patients with early stage of idiopathic pulmonary fibrosis - Efficacy and Safety of Nintedanib in Japanese patients with early stage of idiopathic pulmonary fibrosis

Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences0 sites215 target enrollmentStarted: October 24, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
215

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1)Patients who have initiated therapy with any antifibrotic agent for IPF. 2)Patients treated with corticosteroids (more than a prednisolone equivalent, 10 mg/day) or immunosuppressive agents. 3)Patients who are participating in any other interventional clinical trials. 4)Patients who are undergoing malignant tumor treatment. 5)Patients with a contraindication for nintedanib treatment.

Investigators

Sponsor
Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences

Similar Trials